Green Alpha Advisors, LLC

Position in RXRX — Recursion Pharmaceuticals, Inc.

CIK 1439207 NIWOT, CO

Position in RXRX

as of Mar 31, 2026 · filed Apr 7, 2026 Compact

Position Value

$466,940

-$150,969 QoQ

Shares Held

152,098

+0.7% QoQ

Ownership

0.029%

of shares outstanding

% of Portfolio

0.47%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2023

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Green Alpha Advisors, LLC holds $7,875,497 across 13 Biotechnology names. RXRX ranks #5 (5.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	CRSP	CRISPR Therapeutics AG	57,022	$2,712,536
2	MRNA	Moderna, Inc.	34,338	$1,744,370
3	CRBU	Caribou Biosciences, Inc.	373,650	$709,935
4	PRME	Prime Medicine, Inc.	191,171	$665,275
5	RXRX	Recursion Pharmaceuticals, Inc. This page	152,098	$466,940
6	EDIT	Editas Medicine, Inc.	160,142	$395,550
7	REGN	Regeneron Pharmaceuticals, Inc.	336	$259,607
8	VRTX	Vertex Pharmaceuticals Inc / Ma	546	$243,810

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$466,940	152,098	+0.7%	Shares	Sole	2026-04-07
2025-12-31	$617,909	151,078	-28.8%	Shares	Sole	2026-01-07
2025-09-30	$1,035,545	212,202	+21.2%	Shares	Sole	2025-10-15
2025-06-30	$885,970	175,093	-2.1%	Shares	Sole	2025-08-01
2025-03-31	$946,238	178,873	+166.4%	Shares	Sole	2025-04-09
2024-12-31	$453,900	67,145	+3.6%	Shares	Sole	2025-01-13
2024-09-30	$427,025	64,799	+2.9%	Shares	Sole	2024-10-07
2024-06-30	$472,492	62,999	-13.0%	Shares	Sole	2024-08-13
2024-03-31	$722,166	72,434	+6.7%	Shares	Sole	2024-04-10
2023-12-31	$669,208	67,871	+96.5%	Shares	Sole	2024-01-05
2023-09-30	$264,246	34,542	—	Shares	Sole	2023-10-10
No filing history on record for this holder in this stock.